656 related articles for article (PubMed ID: 27234695)
41. Gated magnetic mesoporous silica nanoparticles for intracellular enzyme-triggered drug delivery.
An N; Lin H; Yang C; Zhang T; Tong R; Chen Y; Qu F
Mater Sci Eng C Mater Biol Appl; 2016 Dec; 69():292-300. PubMed ID: 27612716
[TBL] [Abstract][Full Text] [Related]
42. A pharmaceutical study of doxorubicin-loaded PEGylated nanoparticles for magnetic drug targeting.
Gautier J; Munnier E; Paillard A; Hervé K; Douziech-Eyrolles L; Soucé M; Dubois P; Chourpa I
Int J Pharm; 2012 Feb; 423(1):16-25. PubMed ID: 21703340
[TBL] [Abstract][Full Text] [Related]
43. Chondroitin sulfate-capped super-paramagnetic iron oxide nanoparticles as potential carriers of doxorubicin hydrochloride.
Mallick N; Anwar M; Asfer M; Mehdi SH; Rizvi MMA; Panda AK; Talegaonkar S; Ahmad FJ
Carbohydr Polym; 2016 Oct; 151():546-556. PubMed ID: 27474599
[TBL] [Abstract][Full Text] [Related]
44. Increased Toxicity of Doxorubicin Encapsulated into pH-Responsive Poly(β-Amino Ester)-Functionalized MCM-41 Silica Nanoparticles.
Ávila-Ortega A; Carrillo-Cocom LM; Olán-Noverola CE; Nic-Can GI; Vilchis-Nestor AR; Talavera-Pech WA
Curr Drug Deliv; 2020; 17(9):799-805. PubMed ID: 32723272
[TBL] [Abstract][Full Text] [Related]
45. Synthesis of Cross-linked Poly (N-isopropylacrylamide) Magnetic Nano Composite for Application in the Controlled Release of Doxorubicin.
Kaamyabi S; Badrian A; Akbarzadeh A
Pharm Nanotechnol; 2017; 5(1):67-75. PubMed ID: 28948911
[TBL] [Abstract][Full Text] [Related]
46. Efficient reduction and pH co-triggered DOX-loaded magnetic nanogel carrier using disulfide crosslinking.
Huang J; Xue Y; Cai N; Zhang H; Wen K; Luo X; Long S; Yu F
Mater Sci Eng C Mater Biol Appl; 2015 Jan; 46():41-51. PubMed ID: 25491958
[TBL] [Abstract][Full Text] [Related]
47. Enhanced doxorubicin delivery and cytotoxicity in multidrug resistant cancer cells using multifunctional magnetic nanoparticles.
Pilapong C; Keereeta Y; Munkhetkorn S; Thongtem S; Thongtem T
Colloids Surf B Biointerfaces; 2014 Jan; 113():249-53. PubMed ID: 24103503
[TBL] [Abstract][Full Text] [Related]
48. Intracellular pH-Triggered, Targeted Drug Delivery to Cancer Cells by Multifunctional Envelope-Type Mesoporous Silica Nanocontainers.
Yang K; Luo H; Zeng M; Jiang Y; Li J; Fu X
ACS Appl Mater Interfaces; 2015 Aug; 7(31):17399-407. PubMed ID: 26196506
[TBL] [Abstract][Full Text] [Related]
49. Synthesis of doxorubicin-PLGA loaded chitosan stabilized (Mn, Zn)Fe2O4 nanoparticles: Biological activity and pH-responsive drug release.
Montha W; Maneeprakorn W; Buatong N; Tang IM; Pon-On W
Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():235-240. PubMed ID: 26652369
[TBL] [Abstract][Full Text] [Related]
50. Dual-pH/Magnetic-Field-Controlled Drug Delivery Systems Based on Fe
Hu X; Wang Y; Zhang L; Xu M; Zhang J; Dong W
ChemMedChem; 2017 Oct; 12(19):1600-1609. PubMed ID: 28857472
[TBL] [Abstract][Full Text] [Related]
51. Folic acid conjugated Fe
Rana S; Shetake NG; Barick KC; Pandey BN; Salunke HG; Hassan PA
Dalton Trans; 2016 Nov; 45(43):17401-17408. PubMed ID: 27731450
[TBL] [Abstract][Full Text] [Related]
52. Development and characterization dual responsive magnetic nanocomposites for targeted drug delivery systems.
Ahmadkhani L; Akbarzadeh A; Abbasian M
Artif Cells Nanomed Biotechnol; 2018 Aug; 46(5):1052-1063. PubMed ID: 28754064
[TBL] [Abstract][Full Text] [Related]
53. pH sensitive surfactant-stabilized Fe
Dutta B; Shetake NG; Barick BK; Barick KC; Pandey BN; Priyadarsini KI; Hassan PA
Colloids Surf B Biointerfaces; 2018 Feb; 162():163-171. PubMed ID: 29190467
[TBL] [Abstract][Full Text] [Related]
54. Hybrid Mesoporous Silica-Based Drug Carrier Nanostructures with Improved Degradability by Hydroxyapatite.
Hao X; Hu X; Zhang C; Chen S; Li Z; Yang X; Liu H; Jia G; Liu D; Ge K; Liang XJ; Zhang J
ACS Nano; 2015 Oct; 9(10):9614-25. PubMed ID: 26316321
[TBL] [Abstract][Full Text] [Related]
55. Metal-polyphenol network coated magnetic hydroxyapatite for pH-activated MR imaging and drug delivery.
Jiang W; Wang Q; Cui D; Han L; Chen L; Xu J; Niu N
Colloids Surf B Biointerfaces; 2023 Feb; 222():113076. PubMed ID: 36563416
[TBL] [Abstract][Full Text] [Related]
56. Luminescent mesoporous nanoreservoirs for the effective loading and intracellular delivery of therapeutic drugs.
Kwon S; Singh RK; Kim TH; Patel KD; Kim JJ; Chrzanowski W; Kim HW
Acta Biomater; 2014 Mar; 10(3):1431-42. PubMed ID: 24239681
[TBL] [Abstract][Full Text] [Related]
57. Doxorubicin loaded magnetic gold nanoparticles for in vivo targeted drug delivery.
Elbialy NS; Fathy MM; Khalil WM
Int J Pharm; 2015 Jul; 490(1-2):190-9. PubMed ID: 25997662
[TBL] [Abstract][Full Text] [Related]
58. A surface-grafted ligand functionalization strategy for coordinate binding of doxorubicin at surface of PEGylated mesoporous silica nanoparticles: Toward pH-responsive drug delivery.
Zhang Q; Zhao H; Li D; Liu L; Du S
Colloids Surf B Biointerfaces; 2017 Jan; 149():138-145. PubMed ID: 27750088
[TBL] [Abstract][Full Text] [Related]
59. Facile one-pot synthesis of carbon/calcium phosphate/Fe3O4 composite nanoparticles for simultaneous imaging and pH/NIR-responsive drug delivery.
Gou M; Li S; Zhang L; Li L; Wang C; Su Z
Chem Commun (Camb); 2016 Sep; 52(74):11068-71. PubMed ID: 27561158
[TBL] [Abstract][Full Text] [Related]
60. Synthesis and correction of albumin magnetic nanoparticles with organic compounds for absorbing and releasing doxorubicin hydrochloride.
Hormozi N; Esmaeili A
Colloids Surf B Biointerfaces; 2019 Oct; 182():110368. PubMed ID: 31362156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
